News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Valensa International, LLC: Astaxanthin Stability Breakthrough Achieved by Valensa O2B(R)


8/19/2009 11:58:58 AM

ORLANDO, Fla., Aug. 19 /PRNewswire/ -- Valensa International announced today that it has developed technology that has dramatically increased the stability and shelf-life of the powerful, versatile antioxidant astaxanthin. The company has just completed a 7-year shelf-life study of its Zanthin(R) natural astaxanthin that indicates that this ultra-high pressure supercritical CO2 extract of Haematococcus pluvialis, bolstered by Valensa's proprietary O2B(R) Peroxidation Blocker technology, has a minimum 4-year shelf-life. Published reports by other astaxanthin producers indicate ranges of 1 - 2 years under refrigeration as the existing state-of-the-art for astaxanthin stability. Effective immediately, Valensa has raised its Zanthin(R) brand astaxanthin oleoresin stability recommendation to 4 years at 20 degrees C. The greater stability profile of Zanthin(R) astaxanthin will allow formulators of nutraceutical products to use smaller safety margins (overage) to assure consumers of efficacy in products on a store shelf, which can lead to cost savings.

ZANTHIN(R) - A natural, high efficacy extract with proven quality

For information on Zanthin(R) Natural Astaxanthin, please contact Valensa directly.

SOURCE Valensa International, LLC

CONTACT: Rudi Moerck, President & CEO of Valensa International, LLC,
+1-352-357-2004, or Fax, +1-352-483-2095


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES